Preliminary Program
Stream 2: Drug Design, Screening and Hit to Lead
Session 201: Combinatorial Chemistry
Time: 08:30-12:00, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 202: Molecular Modeling and Simulations
Time: 08:30-12:00, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 203: Computer-Aided Drug Design
Time: 13:30-17:30, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 204: Fragment-based Drug Design
Time: 13:30-17:30, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Dr. Stephan K. Zahn, Scientific Director, Boehringer Ingelheim RCV GmbH & Co KG, Austria
Co-Chair: Call for Co-chair
Session 205: Structure-based Drug Design
Time: 08:30-12:00, November 17, 2019 (Sunday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
|
Time |
FaceOn |
Speeches and Speakers |
|
08:30-08:35 |
Chair's Introduction |
|
|
08:35-09:00 |
|
Dr. Laure Bouchez, Director, Glenmark Therapeutics, USA |
|
09:00-09:25 |
|
Title: |
|
09:25-09:50 |
|
Title: |
|
09:50-10:15 |
|
Title: |
|
10:15-10:30 |
Coffee Break |
|
Session 206: High-throughput Screening & Laboratory Automation
Time: 08:30-12:00, November 17, 2019 (Sunday)
Place: Nanjing, China
Chair: Dr. Xianshu Yang, Principal Scientist, Merck Research Laboratories, USA
Co-Chair: Call for Co-chair
|
Time |
FaceOn |
Speeches and Speakers |
|
08:30-08:35 |
Chair's Introduction |
|
|
08:35-09:00 |
|
Title: |
|
09:00-09:25 |
|
Title: Directly Identifying Protein-bound Ligands from Chemical Mixtures Using an Affinity Selection Mass Spectrometry Platform Dr. Xianshu Yang, Principal Scientist, Merck Research Laboratories, USA |
|
09:25-09:50 |
|
Dr. Thomas D.Y. Chung, Director, Translational Programs Outreach, Sanford Burnham Prebys Medical Discovery Institute, USA |
|
09:50-10:15 |
|
Title: |
|
10:15-10:30 |
Coffee Break |
|
Session 207: Lead Compounds Discovery, Optimization and Structure Modification
Time: 13:30-17:30, November 17, 2019 (Sunday)
Place: Nanjing, China
Chair: Dr. Xing-yue Ji, Professor, Soochow University, China
Co-Chair: Call for Co-chair
|
Time |
FaceOn |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
|
13:35-14:00 |
|
Title: Discovery of a Novel Series of CHK1 Kinase Inhibitors and SAR Mixture Optimization Using the Affinity Selection−mass Spectrometry (AS-MS) Platform Dr. Xianshu Yang, Principal Scientist, Merck Research Laboratories, USA |
|
14:00-14:25 |
|
Dr. Samir Jegham, Lead Generation Senior Advisor for Asia Pacific Reserach Hub, Sanofi, France |
|
14:25-14:50 |
|
Title: Carbon Monoxide Prodrugs for Treating Human Diseases
|
|
14:50-15:15 |
|
Dr. Yue Li, Investigator, GlaxoSmithKline, UK |
|
15:15-15:30 |
Coffee Break |
|
|
15:30-15:55 |
 |
Dr. M.P.Kaushik, Pro Vice Chancellor, Amity University, India |
|
15:55-16:20 |
|
Title: |
|
16:20-16:45 |
|
Title: |
Speaking Proposals are Now Being Accepted
